Validity and Reliability Studies of the Indonesian Version of Heart Failure Somatic Perception Scale (HFSPS) Questionnaire
DOI:
https://doi.org/10.61841/jy628d23Keywords:
Heart Failure, Validity and Reliability, HFSPS, SymptomsAbstract
--- Heart Failure Somatic Perception Scale (HFSPS) is one of the most commonly used questionnaires to assess HF physical symptoms. However, to be utilized in Indonesia, it needs validity and reliability studies. This study aimed to obtain a valid and reliable Indonesian version of the Heart Failure Somatic Perception Scale (HFSPS) so that it can be used in Indonesia. This study was a cross-sectional study with 152 subjects with a mean age of 58.03±10.2 years who had heart failure disease and were treated at the outpatient clinic of cardiology in Government Hospital in Lamongan and Gresik, East Java, Indonesia. The validity of the HFSPS was assessed by evaluating the construct validity using a multitrait-multimethod analysis and external validity was evaluated by comparing the HFSPS with the MLHF questionnaire. Reliability was assessed using Cronbach’s α. All items in the Indonesian version of the HFSPS questionnaire were valid and had a positive strong correlation with the MLHF questionnaire (r=0,635; p<0.000). The Cronbach α of the Indonesian version of HFSPS was 0.813. The Indonesian version of HFSPS has good validity and reliability to assess the physical symptoms of patients with chronic heart failure in Indonesia.
Downloads
References
[1] C. Rogers and N. Bush, “Heart Failure: Pathophysiology, Diagnosis, Medical Treatment Guidelines, and Nursing Management,” Nurs. Clin. North Am., vol. 50, no. 4, pp. 787–799, 2015.
[2] W. Lesyuk, C. Kriza, and P. Kolominsky-Rabas, “Cost-of-illness studies in heart failure: A systematic review 2004-2016,” BMC Cardiovasc. Disord., vol. 18, no. 1, pp. 1–11, 2018.
[3] G. Savarese and H. L. Lund, “Global Public Health Burden of Heart Failure,” Card. Fail. Rev., vol. 3, no. 1,
pp. 7–11, 2017.
[4] Research and Development Board Ministry of Health Republic of Indonesia, “Basic Health Research 2013,” Jakarta, 2013.
[5] G. Pucciarelli et al., “Psychometric evaluation of the heart failure somatic perception scale in a european heart failure population,” Eur. J. Cardiovasc. Nurs., vol. 18, no. 6, pp. 484–491, 2019.
[6] C. Y. Jurgens, C. S. Lee, and B. Riegel, “Psychometric analysis of the Heart Failure Somatic Perception Scale as a measure of patient symptom perception,” J Cardiovasc Nurs, vol. 32, no. 2, pp. 140–147, 2017.
[7] L. Zimmerman et al., “Selecting symptom instruments for cardiovascular populations,” Hear. Lung J. Acute Crit. Care, vol. 45, no. 6, pp. 475–496, 2016.
[8] K. S. Lee and D. K. Moser, “Heart failure symptom measures: Critical review,” Eur. J. Cardiovasc. Nurs., vol. 12, no. 5, pp. 418–428, 2013.
[9] D. E. Beaton, C. Bombardier, F. Guillemin, and M. B. Ferraz, “Guidelines for the Process of Cross-Cultural Adaptation of Self-Report Measures,” Spine (Phila. Pa. 1976)., vol. 25, no. 24, pp. 3186–3191, 2000.
[10] S. Heo et al., “Changes in Heart Failure Symptoms are Associated with Changes in Health-related Quality of Life over 12 Months in Patients with Heart Failure,” J. Cardiovasc. Nurs., vol. 33, no. 5, pp. 460–466, 2018.
[11] D. Y. Kusuma, H. Shatri, I. Alwi, and M. Abdullah, “Validity and Reliability Studies of the Indonesian Version of the Minnesota Living with Heart Failure Questionnaire ( MLHFQ ): Quality of Life Questionnaire for Patients with Chronic Heart Failure,” vol. 51, no. 1, pp. 26–33, 2019.
[12] K. H. Humphries et al., “Sex differences in cardiovascular disease – Impact on care and outcomes,” Front. Neuroendocrinol., vol. 46, pp. 46–70, 2017.
[13] A. Strömberg and J. Mårtensson, “Gender differences in patients with heart failure,” Eur. J. Cardiovasc. Nurs., vol. 2, no. 1, pp. 7–18, 2003.
[14] J. P. Auld, J. O. Mudd, J. M. Gelow, S. O. Hiatt, and C. S. Lee, “Self-care Moderates the Relationship Between Symptoms and Health-Related Quality of Life in Heart Failure,” vol. 00, no. 0, pp. 1–8, 2017.
[15] S. Heo, D. K. Moser, T. A. Lennie, M. Fischer, E. Smith, and M. N. Walsh, “Modifiable correlates of physical symptoms and health-related quality of life in patients with heart failure: A cross-sectional study,” Int. J. Nurs. Stud., vol. 51, no. 11, pp. 1482–1490, 2014.
[16] S. H. Chu et al., “Factors affecting quality of life in Korean patients with chronic heart failure.,” Jpn. J. Nurs. Sci., vol. 11, no. 1, pp. 54–64, Jan. 2014.
[17] E. J. Benjamin et al., “Heart Disease and Stroke Statistics’2017 Update: A Report from the American Heart Association,” Circulation, vol. 135, no. 10, pp. e146–e603, 2017.
[18] C. W. Yancy et al., “2013 ACCF/AHA guideline for the management of heart failure: A report of the American college of cardiology foundation/american heart association task force on practice guidelines,” J. Am. Coll. Cardiol., vol. 62, no. 16, pp. e147–e239, 2013.
[19] A. Inamdar and A. Inamdar, “Heart Failure: Diagnosis, Management and Utilization,” J. Clin. Med., vol. 5, no. 7, p. 62, 2016.
[20] D. K. Moser et al., “Improvement in Health-related Quality of Life After Hospitalization Predicts Event-free Survival in Patients With Advanced Heart Failure,” J. Card. Fail., vol. 15, no. 9, pp. 763–769, 2009.
[21] C. M. Alpert, M. A. Smith, S. L. Hummel, and E. K. Hummel, “Symptom burden in heart failure: assessment, impact on outcomes, and management,” Heart Fail. Rev., vol. 22, no. 1, pp. 25–39, 2017.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
